Podcast

The MedTech Startup Podcast: CEO Mike Kujak

November 21, 2023

Francis Medical CEO Mike Kujak was recently interviewed in an episode of The MedTech Startup Podcast.

Watch as Mike shares what it’s like being a first-time CEO, his fundraising tactics and his philosophy for driving success at Francis Medical.

YouTube Video 38 min.

More on Mike on our Leadership Page

Share this post

Share this post

Recent Posts

  • Dr. Samir Taneja and Northwell Urology team celebrate first commercial Vanquish Water Vapor Ablation procedure in New York
Francis Medical Announces Northwell Urology Group Performs First Commercial Vanquish® Water Vapor Ablation Procedure in New York

August 5th, 2026|

LAKE SUCCESS, NY, August 5, 2026, - Samir S. Taneja, MD, a urologic oncologist, chairman of the Department of Urology at Northwell Health and professor of urology at the Donald and Barbara Zucker School of Medicine, has performed the first commercial Vanquish® Water Vapor Ablation (Vanquish System) procedure in New York state, marking a significant milestone for patients in the region seeking a minimally invasive prostate care option.

  • Dr. Su
Francis Medical Announces Orange County Urology Associates Becomes First in California to Integrate Vanquish® Water Vapor Ablation into Routine Prostate Care

July 7th, 2026|

Maple Grove, Minn., July 7th, 2026 – Daniel Su, MD, a urologist at Orange County Urology Associates (OCUA), has performed the first commercial Vanquish® Water Vapor Ablation procedures in the state of California, offering patients a new minimally invasive Focal Therapy option as part of the group’s prostate care service. The procedure was completed within a single outpatient visit and did not require a hospital stay. Beyond the clinical milestone, Dr. Su’s experience highlights something equally important: how this technology can be adopted into an existing urology practice.

Francis Medical Announces Publication of VAPOR 2 Pivotal Trial Results in The Journal of Urology

June 30th, 2026|

MAPLE GROVE, Minn., June 30, 2026 – Francis Medical, Inc., a medical device company dedicated to advancing minimally invasive therapies for urological cancers, today announced the publication of the initial report from its VAPOR 2 pivotal clinical study in The Journal of Urology, one of the world’s leading peer-reviewed urology journals.